Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Jun 15 NVO Novo Nordisk CEO to testify before Senate on Ozempic pricing
Jun 15 NVO 3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Jun 14 NVO Employee benefits survey finds marked increase in GLP-1 coverage
Jun 14 NVO Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
Jun 14 NVO Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
Jun 14 NVO Eli Lilly unveils new manufacturing plant for GLP-1 pens
Jun 14 NVO IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
Jun 14 REGN Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea
Jun 14 NVO Few IBD 50 Stocks In Buy Zones; Netflix Is One
Jun 14 RNA Avidity Biosciences: Muscular Dystrophy Breakthrough Propels To A 'Buy' Upgrade
Jun 14 REGN Regeneron wins injunction blocking Samsung Bioepis from launching generic Eylea
Jun 14 NVO Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
Jun 14 NVO Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market
Jun 14 RNA Avidity Biosciences to Participate in Upcoming Investor Conference
Jun 14 NVO Employer coverage for GLP-1s rising amid FDA label expansions: survey
Jun 14 MREO Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
Jun 14 INSM Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
Jun 14 IMTX Here's Why Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Is The Least Of Shareholders' Concerns
Jun 14 REGN Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years
Jun 14 NVO Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags